115 related articles for article (PubMed ID: 15019371)
1. Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration.
Olsen TW; Feng X; Kasper TJ; Rath PP; Steuer ER
Ophthalmology; 2004 Feb; 111(2):250-5. PubMed ID: 15019371
[TBL] [Abstract][Full Text] [Related]
2. Autofluorescence imaging in age-related macular degeneration complicated by choroidal neovascularization: a prospective study.
Vaclavik V; Vujosevic S; Dandekar SS; Bunce C; Peto T; Bird AC
Ophthalmology; 2008 Feb; 115(2):342-6. PubMed ID: 17599415
[TBL] [Abstract][Full Text] [Related]
3. Natural course of occult choroidal neovascularization in age-related macular degeneration: development of classic lesions in fluorescein angiography.
Schneider U; Gelisken F; Inhoffen W
Acta Ophthalmol Scand; 2005 Apr; 83(2):141-7. PubMed ID: 15799723
[TBL] [Abstract][Full Text] [Related]
4. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
Kaiser PK; Blodi BA; Shapiro H; Acharya NR;
Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683
[TBL] [Abstract][Full Text] [Related]
5. Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration.
Shah AR; Del Priore LV
Ophthalmology; 2009 Oct; 116(10):1901-7. PubMed ID: 19592101
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.
Maguire MG; Alexander J; Fine SL;
Ophthalmology; 2008 Sep; 115(9):1468-73, 1473.e1-2. PubMed ID: 18486222
[TBL] [Abstract][Full Text] [Related]
7. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J
Retina; 2009; 29(10):1444-9. PubMed ID: 19730163
[TBL] [Abstract][Full Text] [Related]
8. [Frequency of neovascular lesion types in wet age-related macular degeneration].
Gierek-Lapińska A; Wykrota H; Trzciakowski K; Szymkowiak M; Gierek-Ciaciura S
Klin Oczna; 2004; 106(3 Suppl):463-5. PubMed ID: 15636237
[TBL] [Abstract][Full Text] [Related]
9. Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group.
; Solomon SD; Jefferys JL; Hawkins BS; Bressler NM
Arch Ophthalmol; 2007 Oct; 125(10):1323-30. PubMed ID: 17923538
[TBL] [Abstract][Full Text] [Related]
10. Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration.
Malamos P; Sacu S; Georgopoulos M; Kiss C; Pruente C; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4926-33. PubMed ID: 19494200
[TBL] [Abstract][Full Text] [Related]
11. Low power vs standard power transpupillary thermotherapy in patients with age-related macular degeneration and subfoveal choroidal neovascularization ineligible for photodynamic therapy.
Hogan AC; Kilmartin DJ
Eye (Lond); 2006 Jun; 20(6):649-54. PubMed ID: 16082398
[TBL] [Abstract][Full Text] [Related]
12. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD].
Pauleikhoff D; Bornfeld N; Gabel VP; Holz F; Roider H; ; ;
Klin Monbl Augenheilkd; 2005 May; 222(5):381-8. PubMed ID: 15912454
[TBL] [Abstract][Full Text] [Related]
13. Predictors of structural findings in old disciform lesions.
Riusala AM; Immonen IJ
Am J Ophthalmol; 2004 Aug; 138(2):245-53. PubMed ID: 15289134
[TBL] [Abstract][Full Text] [Related]
14. Lesion morphology in age-related macular degeneration and its therapeutic significance.
Beaumont PE; Kang HK
Arch Ophthalmol; 2006 Jun; 124(6):807-12. PubMed ID: 16769834
[TBL] [Abstract][Full Text] [Related]
15. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA
Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
[TBL] [Abstract][Full Text] [Related]
16. Results 28 months following transpupillary thermotherapy for classic and occult choroidal neovascularization in patients with age-related macular degeneration.
Newsom RS; McAlister JC; Saeed M; El-Ghonemy K; McHugh JD
Ophthalmic Surg Lasers Imaging; 2005; 36(2):94-102. PubMed ID: 15792308
[TBL] [Abstract][Full Text] [Related]
17. [Transpupillary thermotherapy in exudative age-related macular degeneration].
Kubicka-Trzaska A; Starzycka M; Ortyl E; Górniak-Bednarz A; Karska-Basta I
Klin Oczna; 2007; 109(4-6):142-5. PubMed ID: 17725272
[TBL] [Abstract][Full Text] [Related]
18. Variability among retina specialists in evaluating fluorescein angiograms of patients with neovascular age-related macular degeneration.
Zayit-Soudry S; Alfasi M; Goldstein M; Moisseiev J; Axer-Siegel R; Pollack A; Yassur Y; Loewenstein A
Retina; 2007; 27(6):798-803. PubMed ID: 17621192
[TBL] [Abstract][Full Text] [Related]
19. Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to management--TAP report No. 6.
Bressler SB; Pieramici DJ; Koester JM; Bressler NM
Arch Ophthalmol; 2004 Mar; 122(3):325-9. PubMed ID: 15006843
[TBL] [Abstract][Full Text] [Related]
20. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD.
Avila MP; Farah ME; Santos A; Kapran Z; Duprat JP; Woodward BW; Nau J
Retina; 2009 Feb; 29(2):157-69. PubMed ID: 19202425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
